Cancer

EDETEK Launches CONFORM™ – ONCO+, a Therapeutic Area-Specific Accelerator for the CONFORM™ Platform

Unveiling AI-Driven Accelerators to Enhance Clinical Trial Efficiency and Precision PRINCETON, N.J., Oct. 23, 2024 /PRNewswire/ -- EDETEK Inc., a…

1 year ago

ACR Poker and Its Players Raise $20,000 for the United Breast Cancer Foundation

SAN JOSE, Costa Rica, Oct. 23, 2024 /PRNewswire/ -- In support of Breast Cancer Awareness Month, ACR Poker hosted its third…

1 year ago

MEDSIR takes part in the Nexus Conference to address the challenges and opportunities of geographic diversity in clinical trials

The conference, held in New Jersey, addresses critical aspects of clinical trials in the biopharmaceutical industry in the United States.Rui…

1 year ago

AngioDynamics and University College London Hospital Launch International Multi-Center Study to Assess Long Term Effects of Treatment with The NanoKnife® System

Investigator initiated trial seeks to validate safety, efficacy of the NanoKnife System in treating targeted tumors while reducing or delaying…

1 year ago

Kronos Bio Data Presentation at EORTC-NCI-AACR Symposium Highlights the Importance of p300 KAT Inhibition in HPV-Driven Tumors

– Preclinical data demonstrate that inhibiting the p300 KAT domain reactivates p53 in HPV-driven tumors resulting in anti-tumor activity –SAN…

1 year ago

Creative Innovation & Investment Shine On Day Two of Global Health Exhibition in Riyadh

World class exhibitors showcase opportunities and challenges posed by frontier-pushing digital and practical health technologies, set to revolutionize patient care…

1 year ago

Complete Blood Count Test with At-Home Sample Collection is Available for Direct-to-Patient Biopharma Programs through ixlayer’s ixEngage

ixEngage removes barriers to care by accelerating pre-treatment and routine CBC tests used for hundreds of conditions, including asthma, heart…

1 year ago

Lin Health to Collaborate with Mayo Clinic to Expand Access to Evidence-Based, Tech-Enabled Chronic Pain Care

Retraining the brain's neural circuitry through a behavioral health approach empowers people living with chronic pain to avoid costly and…

1 year ago

SOPHiA GENETICS to Announce Financial Results for Third Quarter 2024 on November 5, 2024

BOSTON and ROLLE, Switzerland, Oct. 22, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in…

1 year ago

NanoViricides President Dr. Diwan to Present at the PODD Conference

SHELTON, CT / ACCESSWIRE / October 22, 2024 / NanoViricides, Inc. (NYSE Amer.: NNVC ) (the "Company"), a clinical stage…

1 year ago